MarkWide Research

Sale!

Global Pathology Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: September, 2022
No of Pages: 168
Delivery Format: PDF+ Excel

$2,950.00

Global Pathology Market is a branch of medical research that involves the study of the cause, origin, and nature of a disease by examining the body fluids, organ, and tissues. It determines the actual state of the disease to decide the course of treatment of different disease. There are basically of two types, namely digital and anatomical pathology.

Digital pathology involves the use of digitized glass slide for the interpretation of pathology information, while anatomical pathology involves the diagnosis of disease based on microscopic as well as macroscopic examination of organs, tissues, and body fluids. The global pathology market is anticipated to register significant growth during the forecast period due to the growing need for integrated healthcare facilities and growing prevalence of chronic conditions.

Global Pathology Market Report Scope and Segmentation
ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2017-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

The global pathology market is driven by ease of transportation of slides, surge in prevalence of chronic diseases & aging population, and increase in the laboratory workflow efficiency. However, lack of reimbursement and dearth of skilled personnel restrict the market growth. Furthermore, unmet pathological needs in the emerging economies are expected to provide numerous opportunities for the market growth during the forecast period.

The global pathology market is segmented based on products, type, application, end user, and geography. Based on product, it is classified into scanners, software, communication systems, storage systems, instruments, consumables, and services. Based on type, it is divided into human pathology and animal pathology. On the basis of application, it is categorized into disease diagnosis, teleconsultation, drug discovery & development, training & education, and others.

Based on end user, it is divided into pharmaceutical, biotechnology companies, and CROs; hospitals & reference laboratories and academic & government research institutes. The market is analyzed across regions, namely, North America, Europe, Asia-Pacific, and LAMEA further country level analysis of regions is provided to determine the market size and forecast for each segment and sub-segment of the market in various countries across the globe.

The key players profiled in the report include Leica Biosystems Nussloch GMBH, GE Healthcare, Hamamatsu Photonics K.K, microDimensions GmbH, Mikroscan Technologies, Inc., Omnyx LLC., Koninklijke Philips N.V. Healthcare, Huron Digital Pathology Inc., Ventana Medical Systems, Inc., and Apollo Enterprise Imaging Corporation.

Key Benefits

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis of the industry from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis by product elucidates the use of pathological product in detecting cause, origin, and nature of diseases.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market.

Pathology Market Report Highlights

SegmentsSub-segments
By Product
  • Scanners
  • Software
  • Communication Systems
  • Storage Systems
  • Instruments
  • Consumables
  • Services
By Type
  • Human Digital Pathology
  • Animal Digital Pathology
By Application
  • Disease Diagnosis
  • Teleconsultation
  • Drug Discovery & Development
  • Training & Education
  • Others
By End User
  • Pharmaceutical, Biotechnology Companies, and CROs
  • Hospitals & Reference Laboratories
  • Academic & Government Research Institutes
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market PlayersLeica Biosystems Nussloch GMBH, GE Healthcare, Hamamatsu Photonics K.K, microDimensions GmbH, Mikroscan Technologies, Inc., Omnyx LLC., Koninklijke Philips N.V., Huron Digital Pathology Inc., Ventana Medical Systems, Inc., Apollo Enterprise Imaging Corporation

 

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’s Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2021
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis
CHAPTER 4: PATHOLOGY MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Scanners
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Software
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Communication Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Storage Systems
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Instruments
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Consumables
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Services
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
CHAPTER 5: PATHOLOGY MARKET, BY TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Type
5.2. Human Digital Pathology
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Animal Digital Pathology
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: PATHOLOGY MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Disease Diagnosis
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Teleconsultation
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Drug Discovery Development
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Training Education
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: PATHOLOGY MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Pharmaceutical, Biotechnology Companies, And CROs
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Hospitals Reference Laboratories
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Academic Government Research Institutes
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
CHAPTER 8: PATHOLOGY MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product
8.2.3. Market Size and Forecast, By Type
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Pathology Market
8.2.7.1. Market Size and Forecast, By Product
8.2.7.2. Market Size and Forecast, By Type
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Pathology Market
8.2.8.1. Market Size and Forecast, By Product
8.2.8.2. Market Size and Forecast, By Type
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Pathology Market
8.2.9.1. Market Size and Forecast, By Product
8.2.9.2. Market Size and Forecast, By Type
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product
8.3.3. Market Size and Forecast, By Type
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Pathology Market
8.3.7.1. Market Size and Forecast, By Product
8.3.7.2. Market Size and Forecast, By Type
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Pathology Market
8.3.8.1. Market Size and Forecast, By Product
8.3.8.2. Market Size and Forecast, By Type
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Pathology Market
8.3.9.1. Market Size and Forecast, By Product
8.3.9.2. Market Size and Forecast, By Type
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Pathology Market
8.3.10.1. Market Size and Forecast, By Product
8.3.10.2. Market Size and Forecast, By Type
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Pathology Market
8.3.11.1. Market Size and Forecast, By Product
8.3.11.2. Market Size and Forecast, By Type
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest Of Europe Pathology Market
8.3.12.1. Market Size and Forecast, By Product
8.3.12.2. Market Size and Forecast, By Type
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product
8.4.3. Market Size and Forecast, By Type
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Pathology Market
8.4.7.1. Market Size and Forecast, By Product
8.4.7.2. Market Size and Forecast, By Type
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Pathology Market
8.4.8.1. Market Size and Forecast, By Product
8.4.8.2. Market Size and Forecast, By Type
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Pathology Market
8.4.9.1. Market Size and Forecast, By Product
8.4.9.2. Market Size and Forecast, By Type
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Pathology Market
8.4.10.1. Market Size and Forecast, By Product
8.4.10.2. Market Size and Forecast, By Type
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Pathology Market
8.4.11.1. Market Size and Forecast, By Product
8.4.11.2. Market Size and Forecast, By Type
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia Pacific Pathology Market
8.4.12.1. Market Size and Forecast, By Product
8.4.12.2. Market Size and Forecast, By Type
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product
8.5.3. Market Size and Forecast, By Type
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Pathology Market
8.5.7.1. Market Size and Forecast, By Product
8.5.7.2. Market Size and Forecast, By Type
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Pathology Market
8.5.8.1. Market Size and Forecast, By Product
8.5.8.2. Market Size and Forecast, By Type
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Pathology Market
8.5.9.1. Market Size and Forecast, By Product
8.5.9.2. Market Size and Forecast, By Type
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End User
8.5.10. Rest of LAMEA Pathology Market
8.5.10.1. Market Size and Forecast, By Product
8.5.10.2. Market Size and Forecast, By Type
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End User
CHAPTER 9: COMPANY PROFILES
9.1. Leica Biosystems Nussloch GMBH
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. GE Healthcare
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Hamamatsu Photonics K.K
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. MicroDimensions GmbH
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Mikroscan Technologies, Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Omnyx LLC.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Koninklijke Philips N.V.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Huron Digital Pathology Inc.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Ventana Medical Systems, Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Apollo Enterprise Imaging Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments

By Product

  • Scanners
  • Software
  • Communication Systems
  • Storage Systems
  • Instruments
  • Consumables
  • Services

By Type

  • Human Digital Pathology
  • Animal Digital Pathology

By Application

  • Disease Diagnosis
  • Teleconsultation
  • Drug Discovery & Development
  • Training & Education
  • Others

By End User

  • Pharmaceutical, Biotechnology Companies, and CROs
  • Hospitals & Reference Laboratories
  • Academic & Government Research Institutes

 

Leica Biosystems Nussloch GMBH, GE Healthcare, Hamamatsu Photonics K.K, microDimensions GmbH, Mikroscan Technologies, Inc., Omnyx LLC., Koninklijke Philips N.V., Huron Digital Pathology Inc., Ventana Medical Systems, Inc., Apollo Enterprise Imaging Corporation

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF